John P. Hamill - 26 Jul 2022 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Jul 2022, 16:38:04 UTC
Prior SEC filing
07 Mar 2022
Next SEC filing
30 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John P. Hamill

Key filing fact

John P. Hamill filed Form 4 for WINDTREE THERAPEUTICS INC /DE/ (WINT) on 26 Jul 2022.

Key facts

  • This page summarizes John P. Hamill's Form 4 filing for WINDTREE THERAPEUTICS INC /DE/ (WINT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Jul 2022, 16:38.

Change

  • Previous filing in this sequence was filed on 07 Mar 2022.
  • Current net transaction value: +$1,100.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WINT transaction

Common Stock

Purchase

Transaction value
$1,100
Shares
+3,000
Change %
+4.3%
Price
$0.3666
Shares after
72,800
Date
26 Jul 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares were purchased in multiple trades at prices ranging from $0.3639 to $0.37. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .